Natixis’s Ionis Pharmaceuticals IONS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-16,626
| Closed | -$581K | – | 1058 |
|
|
2024
Q4 | $581K | Buy |
+16,626
| New | +$581K | ﹤0.01% | 667 |
|
|
2024
Q3 | – | Sell |
-163
| Closed | -$7.77K | – | 1022 |
|
|
2024
Q2 | $7.77K | Sell |
163
-1,798
| -92% | -$85.7K | ﹤0.01% | 862 |
|
|
2024
Q1 | $85K | Sell |
1,961
-917
| -32% | -$39.8K | ﹤0.01% | 770 |
|
|
2023
Q4 | $146K | Buy |
+2,878
| New | +$146K | ﹤0.01% | 727 |
|
|
2023
Q1 | – | Sell |
-159,678
| Closed | -$6.03M | – | 1052 |
|
|
2022
Q4 | $6.03M | Buy |
159,678
+25,597
| +19% | +$967K | 0.03% | 325 |
|
|
2022
Q3 | $5.94M | Buy |
+134,081
| New | +$5.94M | 0.03% | 366 |
|
|
2022
Q1 | – | Sell |
-300,797
| Closed | -$9.15M | – | 1241 |
|
|
2021
Q4 | $9.15M | Buy |
+300,797
| New | +$9.15M | 0.03% | 418 |
|
|
2021
Q3 | – | Sell |
-8,530
| Closed | -$340K | – | 1241 |
|
|
2021
Q2 | $340K | Buy |
8,530
+2,871
| +51% | +$114K | ﹤0.01% | 773 |
|
|
2021
Q1 | $254K | Buy |
5,659
+1,792
| +46% | +$80.4K | ﹤0.01% | 1008 |
|
|
2020
Q4 | $219K | Sell |
3,867
-88,089
| -96% | -$4.99M | ﹤0.01% | 991 |
|
|
2020
Q3 | $4.36M | Buy |
91,956
+83,746
| +1,020% | +$3.97M | 0.03% | 297 |
|
|
2020
Q2 | $484K | Buy |
+8,210
| New | +$484K | ﹤0.01% | 622 |
|
|
2019
Q3 | – | Sell |
-99,891
| Closed | -$6.42M | – | 868 |
|
|
2019
Q2 | $6.42M | Buy |
99,891
+75,880
| +316% | +$4.88M | 0.05% | 281 |
|
|
2019
Q1 | $1.92M | Buy |
+24,011
| New | +$1.92M | 0.01% | 501 |
|
|
2018
Q2 | – | Sell |
-12,114
| Closed | -$534K | – | 932 |
|
|
2018
Q1 | $534K | Buy |
+12,114
| New | +$534K | ﹤0.01% | 663 |
|